COIN vs CUE · P/E 64, rev $7.18B vs rev $9.3M
Coinbase Global Inc (COIN) versus Cue Biopharma (CUE) — a side-by-side from cached financials, not a winner call.
Coinbase Global Inc (COIN) is a financial data & stock exchanges company listed on US. It is led by Brian Armstrong.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Latest reported COIN revenue for 2025-12-31 was $7.18B. Net income was $1.26B. Revenue was up 9.4% from 2024-12-31 to 2025-12-31. COIN currently screens at market cap $45.84B and trailing P/E 64.2.
Latest reported CUE revenue for 2024-12-31 was $9.3M. Net income was -$40.7M. Revenue was up 69.2% from 2023-12-31 to 2024-12-31. CUE currently screens at market cap $59.5M.
COIN currently screens at market cap $45.84B and trailing P/E 64.2. CUE currently screens at market cap $59.5M.
Not investment advice. Open the COIN and CUE stock pages for the full models.
Not investment advice.